Carlsmed CEO on IPO, Personalized Spine Surgery, and 100% Revenue Growth

Carlsmed's Mission and Approach

• 🎯 Carlsmed is a medical technology company focused on transforming spinal surgery through personalized solutions.
• 💡 They utilize digital imaging and surgical inputs to create virtual surgical plans.
• 🛠️ 3D printing is used to produce personalized devices on demand, delivered directly to the operating room.

The Digital Production System

• 🚀 The company has developed a proprietary, end-to-end digital production system.
• ⏱️ This system has reduced the planning and device creation process from over eight weeks to two weeks or less.
• ✅ This on-demand model allows for agile and precise execution of complex spinal surgeries.

Business Model and IPO Strategy

• 📈 Carlsmed differentiates itself from traditional medical device companies by not carrying inventory and printing devices on demand.
• 💰 The recent $100 million IPO aims to reinvest capital for growth and expand the reach of their technology.
• 🌍 The company sees its platform technology as applicable beyond current spinal fusion indications.

Financial Performance and Outlook

• 📊 Carlsmed experienced 100% year-over-year revenue growth in the first quarter of the year.
• 🌟 They anticipate continued wide adoption and see their approach becoming a new standard of care.
• 🇺🇸 The company's supply chain is 100% in the US, insulating them from tariff-related issues.